Remarkably different results between two studies from North America on genomic mutations and sensitivity to DNA demethylating agents for myelodysplastic syndromes

<正>Sekeres et al.(1)conducted a multicenter randomized,controlled trial to compare whether azacitidine-based combinations with lenalidomide or vorinostat produce superior overall response rates to azacitidine in the treatment of myelodysplastic syndromes(MDS).In that trial,224 patients...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Chinese journal of cancer research 2017-12, Vol.29 (6), p.587-588
Hauptverfasser:	Wang, Guiping, Guo, Shanshan, Xiao, Huashi, Zong, Liang, Asakawa, Tetsuya, Abe, Masanobu, Hu, Wenqing, Ji, Jiafu
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!